IKS04 Regimen in Advanced Solid Tumors That Express CA242
Clinical trial NCT07738939 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07738939
- Sponsor
- Iksuda Therapeutics Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2028-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.